Minor Injuries Units
Primary Care Services
End of Life Care
Trust HQ, Tatchbury Mount Calmore
Southampton SO40 2RZ
Tel No: 023 8087 4000
PPiP2: Prevalence of Pathogenic Antibodies in Psychosis
This study aims to estimate the prevalence of antibodies against neuronal cell surface targets in patients with psychotic symptoms.
To take part you must:
• Be aged between 18-70.
• Have acute psychosis symptoms: lasting for at least the past two weeks but no longer than two years.
• Patients can have a total history of psychosis longer than 2 years, as long as there has been a period of at least six months of remission prior to the current episode. The current episode should be less than 2 years long.
NOTE: You cannot take part if any of the following apply:
• Any other neurological disorders including multiple sclerosis, epilepsy, cerebrovascular disease, hydrocephalus, traumatic brain injury, meningo-encephalitis, systemic lupus erythematosus, CNS vasculitis.
• Primary drug induced psychosis
If you would like to take part or want more information please contact the study lead:
Study Contact: Marek Czeladzki
Tel: 02380 475943